Ann Lab Med.  2018 Jan;38(1):74-76. 10.3343/alm.2018.38.1.74.

A Case of Anti-reticulin Antibody-positivity in Metachronous Double Primary Cancer

• Kim KN
• Jearn LH
• Kim TY

• KMID: 2397608
• DOI: http://doi.org/10.3343/alm.2018.38.1.74

Abstract

No abstract available.

MeSH Terms

Reticulin*
Autoantibodies*
Collagen*
Neoplasms
Fluorescent Antibody Technique, Indirect
Neoplasms, Second Primary
Antibodies, Antinuclear
Adenocarcinoma
Carcinoma, Transitional Cell
Urinary Bladder Neoplasms
Antibodies, Antinuclear
Reticulin
Autoantibodies
Collagen

Figure

• 

  Fig. 1 Staining of anti-reticulin antibody (ARA) in a patient with metachronous double primary cancer using an indirect immunofluorescence method (×200, fluorescein isothiocyanate). (A) Staining surrounding the liver parenchyma, sinusoid, and portal vein was observed using the rat liver substrate (×200). (B) Staining of the perivascular, periglomerular, and peritubular areas was observed using the rat kidney substrate (×200). (C) Staining of the perivascular area and between the gastric glands was observed using the rat stomach substrate (×200).

Reference

1. Ebrahimnezhad S, Jazayeri M, Hassanian SM, Avan A. Current status and prospective regarding the therapeutic potential of natural autoantibodies in cancer therapy. J Cell Physiol. 2017; 232:2649–2652.

2. Unsworth DJ. ACP Broadsheet No 149: September 1996. Serological diagnosis of gluten sensitive enteropathy. J Clin Pathol. 1996; 49:704–711.

3. Seah PP, Fry L, Holborow EJ, Rossiter MA, Doe WF, Magalhaes AF, et al. Antireticulin antibody: incidence and diagnostic significance. Gut. 1973; 14:311–315.

4. Rizzetto M, Doniach D. Types of ‘reticulin’ antibodies detected in human sera by immunofluorescence. J Clin Pathol. 1973; 26:841–851.

5. Eterman KP, Feltkamp TE. Antibodies to gluten and reticulin in gastrointestinal diseases. Clin Exp Immunol. 1978; 31:92–99.

6. Mascart-Lemone F, Van den Broeck J, Cadranel S, Colombel JF. Serological aspects of coeliac disease. Acta Gastroenterol Belg. 1992; 55:200–208.

7. Ioannou Y, Isenberg DA. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum. 2000; 43:1431–1442.

8. Ronnblom LE, Alm GV, Oberg K. Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment. Acta Oncol. 1991; 30:537–540.